Rev Esp Quimioter 2023;36(Suppl.1):29-32

Mpox global outbreak: update in epidemiology, clinical spectrum and considerations in prevention and treatment

SANTIAGO FERNÁNDEZ-CASTELAO, EVA ORVIZ

Published: 24 November 2023

http://www.doi.org/10.37201/req/s01.08.2023

ABSTRACT
Mpox is the most prevalent Orthopoxvirus infection in humans. Several clinical characteristics of mpox distinguish this disease from other rash illnesses. Complications are not uncommon. New therapeutics and vaccines are likely to change the course of the disease, especially in immunocompromised individuals. Clinicians must ensure that access to treatment and prevention measures are guaranteed especially in this particular population. This review exposes the epidemiology, clinical spectrum and updated considerations in treatment and prevention within the mpox global outbreak.

Rev Esp Quimioter 2023; 36(Suppl.1):29-32 [Full-text PDF]